Increase in WAT eosinophils and M2 macrophages with increased expression of M2 markers (YM1 and Arg-1). Increase in body insulin sensitivity and glucose tolerance, diminished hepatic steatosis. The gene discussed is INS; the disease is fatty liver disease.